Advanced search
Publication Cover
Emerging Microbes & Infections Volume 12, 2023 - Issue 1
Submit an article Journal homepage
3,000
Views
1
CrossRef citations to date
0
Altmetric
Hepatitis

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial

Guohua Zhonga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Chunlan Zhuanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Xiaowen Hua State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Qi Chena State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Zhaofeng Bia State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Xinhua Jiaa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Siying Penga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Yufei Lia State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of ChinaView further author information
,
Yue Huanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b Xiang’an Biomedicine Laboratory, Xiamen, People’s Republic of ChinaView further author information
,
Qiufen Zhangc Xiamen Innovax Biotech Company, Xiamen, People’s Republic of ChinaView further author information
,
Ying Hongd The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Youlin Qiaoe National Cancer Center, National Center for Cancer Clinical Research, the Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, People’s Republic of ChinaView further author information
,
Yingying Sua State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b Xiang’an Biomedicine Laboratory, Xiamen, People’s Republic of ChinaView further author information
,
Huirong Panc Xiamen Innovax Biotech Company, Xiamen, People’s Republic of ChinaView further author information
,
Ting Wua State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b Xiang’an Biomedicine Laboratory, Xiamen, People’s Republic of ChinaView further author information
,
Lihui Weif Peking University People’s Hospital, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Shoujie Huanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b Xiang’an Biomedicine Laboratory, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Jun Zhanga State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b Xiang’an Biomedicine Laboratory, Xiamen, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-6601-9180View further author information
ORCID Icon &
Ningshao Xiaa State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, People’s Republic of China;b Xiang’an Biomedicine Laboratory, Xiamen, People’s Republic of China;g The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0179-5266View further author information
ORCID Icon show all
Article: 2185456 | Received 20 Dec 2022, Accepted 23 Feb 2023, Published online: 15 Mar 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.